AFAP1L2 and hepatocellular carcinoma: Our analyses of T cell proteomes in HCC revealed that AFAP1L2 was uniquely expressed in CD8 TILs in a subset of patients with high percentages of PD1+ TILs, indicative of highly stimulated and proliferative T cells within the TME.